Big Pharma allows millions of people to alleviate debilitating pain, manage dangerous and chronic diseases, mitigate their ...

GlaxoSmithKline (GSK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Smith from ...

GlaxoSmithKline (GSK) has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for its regulatory ...

In a report released today, Rajan Sharma from Goldman Sachs maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target of £16.90. The company’s shares opened today at ...

The World Bank’s ‘one stop shop’ bid to up investment. Plus, we list down the Inter-American Development Bank's top 10 ...

North America Leads in Revenue Share with Robust Immunization Infrastructure while Asia-Pacific Drives Fastest Growth Fueled ...

Centrum addresses growing joint health concerns with launch of Centrum Joint & Mobility Capsule in India: Our Bureau, Mumbai Wednesday, November 27, 2024, 14:30 Hrs [IST] Centrum, ...

A novel asthma burden score that incorporated asthma exacerbations and healthcare utilization better reflected disease ...

In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) ...

Harvey Jones bought GSK shares hoping to bag a solid second income stream while nailing down steady share price growth as well. Sadly, it hasn't turned out that way. The post Down 25% with a 4.32% ...

Report with market evolution powered by AI - The global gastroparesis drugs market size is estimated to grow by USD 1.42 ...

As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the ...